1
|
Jaehne EJ, Semaan H, Grosman A, Xu X, Schwarz Q, van den Buuse M. Enhanced methamphetamine sensitisation in a rat model of the brain-derived neurotrophic factor Val66Met variant: Sex differences and dopamine receptor gene expression. Neuropharmacology 2023; 240:109719. [PMID: 37742717 DOI: 10.1016/j.neuropharm.2023.109719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 08/29/2023] [Accepted: 09/17/2023] [Indexed: 09/26/2023]
Abstract
Brain-derived neurotrophic factor (BDNF) and the Val66Met polymorphism may play a role in the development of psychosis and schizophrenia. The aim of this study was to investigate long-term effects of methamphetamine (Meth) on psychosis-like behaviour and dopamine receptor and dopamine transporter gene expression in a novel rat model of the BDNF Val66Met polymorphism. At the end of a 7-day subchronic Meth treatment, female rats with the Met/Met genotype selectively showed locomotor hyperactivity sensitisation to the acute effect of Meth. Male rats showed tolerance to Meth irrespective of Val66Met genotype. Two weeks later, female Met/Met rats showed increased locomotor activity following both saline treatment or a low dose of Meth, a hyperactivity which was not observed in other genotypes or in males. Baseline PPI did not differ between the groups but the disruption of PPI by acute treatment with apomorphine was absent in Meth-pretreated Met/Met rats. Female Met/Met rats selectively showed down-regulation of dopamine D2 receptor gene expression in striatum. Behavioural effects of MK-801 or its locomotor sensitisation by prior Meth pretreatment were not influenced by genotype. These data suggest a selective vulnerability of female Met/Met rats to short-term and long-term effects of Meth, which could model increased vulnerability to psychosis development associated with the BDNF Val66Met polymorphism.
Collapse
Affiliation(s)
- Emily J Jaehne
- Department of Psychology and Counselling, School of Psychology and Public Health, La Trobe University, Melbourne, Australia
| | - Hayette Semaan
- Department of Psychology and Counselling, School of Psychology and Public Health, La Trobe University, Melbourne, Australia
| | - Adam Grosman
- Department of Psychology and Counselling, School of Psychology and Public Health, La Trobe University, Melbourne, Australia
| | - Xiangjun Xu
- Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
| | - Quenten Schwarz
- Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
| | - Maarten van den Buuse
- Department of Psychology and Counselling, School of Psychology and Public Health, La Trobe University, Melbourne, Australia; Department of Pharmacology, University of Melbourne, Melbourne, Australia.
| |
Collapse
|
2
|
Benzerouk F, Gierski F, Lannoy S, Barrière S, Schmid F, Papillon CA, Houchi H, DeWever E, Quaglino V, Naassila M, Kaladjian A. Brain-derived neurotrophic factor Val66Met polymorphism moderates the relationship between impulsivity, negative emotions, and binge drinking intensity in university students. Alcohol Alcohol 2023; 58:505-511. [PMID: 37334438 DOI: 10.1093/alcalc/agad043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 05/17/2023] [Accepted: 05/28/2023] [Indexed: 06/20/2023] Open
Abstract
Studies on the genetic factors involved in binge drinking (BD) and its associated traits are very rare. The aim of this cross-sectional study was to investigate differences in the association between impulsivity, emotion regulation and BD in a sample of young adults according to the rs6265/Val66Met variant in the brain-derived neurotrophic factor (BDNF) gene, a well-known candidate gene in alcohol use disorders. We recruited 226 university students (112 women), aged between 18 and 25 years old, from two centers in France. The participants completed measures related to alcohol consumption, depression severity, state anxiety levels, impulsivity (UPPS-P), and difficulties in emotion regulation [Difficulty in Emotion Regulation Scale (DERS)]. The relationship between the BD score and the clinical characteristics in the BDNF genotype groups was assessed by partial correlation analyses and moderation analyses. The partial correlation analyses showed that, in the Val/Val genotype group, the BD score was positively related to UPPS-P Lack of Premeditation and Sensation Seeking scores. In the Met carriers group, the BD score was positively related to UPPS-P Positive Urgency, lack of Premeditation, lack of Perseverance and Sensation Seeking scores and to Clarity score of the DERS. Moreover, the BD score was positively associated with depression severity and state anxiety scores. The moderation analyses revealed that BDNF Val/Met genotype moderated the relationship between several clinical variables and BD. The results of the present study support the hypothesis of common and specific vulnerability factors regarding impulsivity and emotion regulation difficulties associated with BD according to this BDNF rs6265 polymorphism.
Collapse
Affiliation(s)
- Farid Benzerouk
- University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France
- Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France
- Institute of Psychiatry and Addictions, Paris, France
- Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France
| | - Fabien Gierski
- University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France
- Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France
- Institute of Psychiatry and Addictions, Paris, France
- Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France
| | - Séverine Lannoy
- Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0126, United States
| | - Sarah Barrière
- Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France
| | - Franca Schmid
- University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France
| | - Charles-Antoine Papillon
- Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France
| | - Hakim Houchi
- Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France
| | - Elodie DeWever
- CRP-CPO Laboratory (EA7273), Jules Verne Picardie University, 80025 Amiens, France
| | - Véronique Quaglino
- CRP-CPO Laboratory (EA7273), Jules Verne Picardie University, 80025 Amiens, France
| | - Mickael Naassila
- Institute of Psychiatry and Addictions, Paris, France
- Research Group on Alcohol and Pharmacodependences, INSERM UMRS 1247, University of Picardy Jules Verne, 80054 Amiens, France
| | - Arthur Kaladjian
- University of Reims Champagne-Ardenne, 51100 Reims, France; Cognition Health Society Laboratory (C2S-EA 6e291), 51100 Reims, France
- Department of Psychiatry, Marne Public Mental Health Institution & Reims University Hospital, 51100 Reims, France
- Institute of Psychiatry and Addictions, Paris, France
| |
Collapse
|
3
|
Jaehne EJ, McInerney E, Sharma R, Genders SG, Djouma E, van den Buuse M. A Rat Model of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism Shows Attenuated Motivation for Alcohol Self-Administration and Diminished Propensity for Cue-Induced Relapse in Females. BIOLOGY 2023; 12:799. [PMID: 37372084 DOI: 10.3390/biology12060799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Revised: 05/25/2023] [Accepted: 05/30/2023] [Indexed: 06/29/2023]
Abstract
Brain-derived neurotrophic factor (BDNF) has been implicated in alcohol use disorder. The Val66Met polymorphism is a common variant of the BDNF gene (rs6265) which reduces activity-dependent BDNF release, and has been suggested as a risk factor for psychiatric disorders and substance use. Using an operant self-administration paradigm, this study aimed to investigate ethanol preference and ethanol seeking in a novel rat model of the BDNF Val66Met polymorphism, Val68Met rats. Male and female BDNF Val68Met rats of three genotypes (Val/Val, Val/Met and Met/Met) were trained to lever press for a 10% ethanol solution. There was no effect of Val68Met genotype on acquisition of stable response to ethanol or its extinction. Met/Met rats of both sexes had a slight, but significantly lower breakpoint during progressive ratio sessions while female rats with the Met/Met genotype demonstrated a lower propensity for reinstatement of responding to cues. There were no effects of Val68Met genotype on anxiety-like behaviour or locomotor activity. In conclusion, Met/Met rats showed lower motivation to continue to press for a reward, and also a decreased propensity to relapse, suggesting a possible protective effect of the Met/Met genotype against alcohol use disorder, at least in females.
Collapse
Affiliation(s)
- Emily J Jaehne
- Department of Psychology, Counselling and Therapy, School of Psychology and Public Health, La Trobe University, Melbourne 3086, Australia
| | - Elizabeth McInerney
- Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne 3086, Australia
| | - Ronan Sharma
- Department of Psychology, Counselling and Therapy, School of Psychology and Public Health, La Trobe University, Melbourne 3086, Australia
| | - Shannyn G Genders
- Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne 3086, Australia
| | - Elvan Djouma
- Department of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne 3086, Australia
| | - Maarten van den Buuse
- Department of Psychology, Counselling and Therapy, School of Psychology and Public Health, La Trobe University, Melbourne 3086, Australia
- Department of Pharmacology, University of Melbourne, Melbourne 3052, Australia
| |
Collapse
|
4
|
Memar S, Jiang E, Prado VF, Saksida LM, Bussey TJ, Prado MAM. Open science and data sharing in cognitive neuroscience with MouseBytes and MouseBytes. Sci Data 2023; 10:210. [PMID: 37059739 PMCID: PMC10104860 DOI: 10.1038/s41597-023-02106-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2022] [Accepted: 03/27/2023] [Indexed: 04/16/2023] Open
Abstract
Open access to rodent cognitive data has lagged behind the rapid generation of large open-access datasets in other areas of neuroscience, such as neuroimaging and genomics. One contributing factor has been the absence of uniform standardization in experiments and data output, an issue that has particularly plagued studies in animal models. Touchscreen-automated cognitive testing of animal models allows standardized outputs that are compatible with open-access sharing. Touchscreen datasets can be combined with different neuro-technologies such as fiber photometry, miniscopes, optogenetics, and MRI to evaluate the relationship between neural activity and behavior. Here we describe a platform that allows deposition of these data into an open-access repository. This platform, called MouseBytes, is a web-based repository that enables researchers to store, share, visualize, and analyze cognitive data. Here we present the architecture, structure, and the essential infrastructure behind MouseBytes. In addition, we describe MouseBytes+, a database that allows data from complementary neuro-technologies such as imaging and photometry to be easily integrated with behavioral data in MouseBytes to support multi-modal behavioral analysis.
Collapse
Affiliation(s)
- Sara Memar
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
| | - Eric Jiang
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
| | - Vania F Prado
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
| | - Lisa M Saksida
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
- Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada
| | - Timothy J Bussey
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
| | - Marco A M Prado
- BrainsCAN, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Robarts Research Institute, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
- Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, N6A 3K7, Canada.
| |
Collapse
|
5
|
Peregud DI, Baronets VY, Terebilina NN, Gulyaeva NV. Role of BDNF in Neuroplasticity Associated with Alcohol Dependence. BIOCHEMISTRY (MOSCOW) 2023; 88:404-416. [PMID: 37076286 DOI: 10.1134/s0006297923030094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/28/2023]
Abstract
Abstract
Chronic alcohol consumption is characterized by disturbances of neuroplasticity. Brain-derived neurotrophic factor (BDNF) is believed to be critically involved in this process. Here we aimed to review actual experimental and clinical data related to BDNF participation in neuroplasticity in the context of alcohol dependence. As has been shown in experiments with rodents, alcohol consumption is accompanied by the brain region-specific changes of BDNF expression and by structural and behavioral impairments. BDNF reverses aberrant neuroplasticity observed during alcohol intoxication. According to the clinical data parameters associated with BDNF demonstrate close correlation with neuroplastic changes accompanying alcohol dependence. In particular, the rs6265 polymorphism within the BDNF gene is associated with macrostructural changes in the brain, while peripheral BDNF concentration may be associated with anxiety, depression, and cognitive impairment. Thus, BDNF is involved in the mechanisms of alcohol-induced changes of neuroplasticity, and polymorphisms within the BDNF gene and peripheral BDNF concentration may serve as biomarkers, diagnostic or prognostic factors in treatment of alcohol abuse.
Collapse
Affiliation(s)
- Danil I Peregud
- Federal State Budgetary Institution "V. Serbsky National Medical Research Center for Psychiatry and Drug Addiction" of the Ministry of Health of the Russian Federation, Moscow, 119002, Russia.
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, 117485, Russia
| | - Valeria Yu Baronets
- Federal State Budgetary Institution "V. Serbsky National Medical Research Center for Psychiatry and Drug Addiction" of the Ministry of Health of the Russian Federation, Moscow, 119002, Russia
| | - Natalia N Terebilina
- Federal State Budgetary Institution "V. Serbsky National Medical Research Center for Psychiatry and Drug Addiction" of the Ministry of Health of the Russian Federation, Moscow, 119002, Russia
| | - Natalia V Gulyaeva
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, 117485, Russia
- Research and Clinical Center for Neuropsychiatry of Moscow Healthcare Department, Moscow, 115419, Russia
| |
Collapse
|
6
|
Starski P, Maulucci D, Mead H, Hopf F. Adaptation of the 5-choice serial reaction time task to measure engagement and motivation for alcohol in mice. Front Behav Neurosci 2022; 16:968359. [PMID: 36187376 PMCID: PMC9522902 DOI: 10.3389/fnbeh.2022.968359] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Accepted: 08/30/2022] [Indexed: 11/13/2022] Open
Abstract
Alcohol use disorder (AUD) is related to excessive binge alcohol consumption, and there is considerable interest in associated factors that promote intake. AUD has many behavioral facets that enhance inflexibility toward alcohol consumption, including impulsivity, motivation, and attention. Thus, it is important to understand how these factors might promote responding for alcohol and can change after protracted alcohol intake. Previous studies have explored such behavioral factors using responding for sugar in the 5-Choice Serial Reaction Time Task (5-CSRTT), which allows careful separation of impulsivity, attention, and motivation. Importantly, our studies uniquely focus on using alcohol as the reward throughout training and testing sessions, which is critical for beginning to answer central questions relating to behavioral engagement for alcohol. Alcohol preference and consumption in male C57BL/6 mice were determined from the first 9 sessions of 2-h alcohol drinking which were interspersed among 5-CSRTT training. Interestingly, alcohol preference but not consumption level significantly predicted 5-CSRTT responding for alcohol. In contrast, responding for strawberry milk was not related to alcohol preference. Moreover, high-preference (HP) mice made more correct alcohol-directed responses than low-preference (LP) during the first half of each session and had more longer reward latencies in the second half, with no differences when performing for strawberry milk, suggesting that HP motivation for alcohol may reflect “front-loading.” Mice were then exposed to an Intermittent Access to alcohol paradigm and retested in 5-CSRTT. While both HP and LP mice increased 5-CSRTT responding for alcohol, but not strawberry milk, LP performance rose to HP levels, with a greater change in correct and premature responding in LP versus HP. Overall, this study provides three significant findings: (1) alcohol was a suitable reward in the 5-CSRTT, allowing dissection of impulsivity, attention, and motivation in relation to alcohol drinking, (2) alcohol preference was a more sensitive indicator of mouse 5-CSRTT performance than consumption, and (3) intermittent alcohol drinking promoted behavioral engagement with alcohol, especially for individuals with less initial engagement.
Collapse
Affiliation(s)
- Phillip Starski
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States
| | - Danielle Maulucci
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States
| | - Hunter Mead
- Department of Psychology, Indiana University-Purdue University Indianapolis (IUPUI), Indianapolis, IN, United States
| | - Frederic Hopf
- Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, United States
- *Correspondence: Frederic Hopf,
| |
Collapse
|
7
|
Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory. Transl Psychiatry 2022; 12:93. [PMID: 35256586 PMCID: PMC8901920 DOI: 10.1038/s41398-022-01858-5] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 02/10/2022] [Accepted: 02/16/2022] [Indexed: 01/02/2023] Open
Abstract
The common brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with reduced activity-dependent BDNF release and increased risk for anxiety disorders and PTSD. Here we behaviorally phenotyped a novel Val66Met rat model with an equivalent valine to methionine substitution in the rat Bdnf gene (Val68Met). In a three-day fear conditioning protocol of fear learning and extinction, adult rats with the Met/Met genotype demonstrated impaired fear memory compared to Val/Met rats and Val/Val controls, with no genotype differences in fear learning or extinction. This deficit in fear memory occurred irrespective of the sex of the animals and was not seen in adolescence (4 weeks of age). There were no changes in open-field locomotor activity or anxiety measured in the elevated plus maze (EPM) nor in other types of memory measured using the novel-object recognition test or Y-maze. BDNF exon VI expression in the dorsal hippocampus was higher and BDNF protein level in the ventral hippocampus was lower in female Val/Met rats than female Val/Val rats, with no other genotype differences, including in total BDNF, BDNF long, or BDNF IV mRNA. These data suggest a specific role for the BDNF Met/Met genotype in fear memory in rats. Further studies are required to investigate gene-environment interactions in this novel animal model.
Collapse
|
8
|
Ahuja P, Ng CF, Pang BPS, Chan WS, Tse MCL, Bi X, Kwan HLR, Brobst D, Herlea-Pana O, Yang X, Du G, Saengnipanthkul S, Noh HL, Jiao B, Kim JK, Lee CW, Ye K, Chan CB. Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice. Autophagy 2021; 18:1367-1384. [PMID: 34689722 DOI: 10.1080/15548627.2021.1985257] [Citation(s) in RCA: 33] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Mitochondrial remodeling is dysregulated in metabolic diseases but the underlying mechanism is not fully understood. We report here that BDNF (brain derived neurotrophic factor) provokes mitochondrial fission and clearance in skeletal muscle via the PRKAA/AMPK-PINK1-PRKN/Parkin and PRKAA-DNM1L/DRP1-MFF pathways. Depleting Bdnf expression in myotubes reduced fatty acid-induced mitofission and mitophagy, which was associated with mitochondrial elongation and impaired lipid handling. Muscle-specific bdnf knockout (MBKO) mice displayed defective mitofission and mitophagy, and accumulation of dysfunctional mitochondria in the muscle when they were fed with a high-fat diet (HFD). These animals also have exacerbated body weight gain, increased intramyocellular lipid deposition, reduced energy expenditure, poor metabolic flexibility, and more insulin resistance. In contrast, consuming a BDNF mimetic (7,8-dihydroxyflavone) increased mitochondrial content, and enhanced mitofission and mitophagy in the skeletal muscles. Hence, BDNF is an essential myokine to maintain mitochondrial quality and function, and its repression in obesity might contribute to impaired metabolism.Abbreviation: 7,8-DHF: 7,8-dihydroxyflavone; ACACA/ACC: acetyl Coenzyme A carboxylase alpha; ACAD: acyl-Coenzyme A dehydrogenase family; ACADVL: acyl-Coenzyme A dehydrogenase, very long chain; ACOT: acyl-CoA thioesterase; CAMKK2: calcium/calmodulin-dependent protein kinase kinase 2, beta; BDNF: brain derived neurotrophic factor; BNIP3: BCL2/adenovirus E1B interacting protein 3; BNIP3L/NIX: BCL2/adenovirus E1B interacting protein 3-like; CCL2/MCP-1: chemokine (C-C motif) ligand 2; CCL5: chemokine (C-C motif) ligand 5; CNS: central nervous system; CPT1B: carnitine palmitoyltransferase 1b, muscle; Cpt2: carnitine palmitoyltransferase 2; CREB: cAMP responsive element binding protein; DNM1L/DRP1: dynamin 1-like; E2: estrogen; EHHADH: enoyl-CoenzymeA hydratase/3-hydroxyacyl CoenzymeA dehydrogenase; ESR1/ER-alpha: estrogen receptor 1 (alpha); FA: fatty acid; FAO: fatty acid oxidation; FCCP: carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone; FFA: free fatty acids; FGF21: fibroblast growth factor 21; FUNDC1: FUN14 domain containing 1; HADHA: hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha; HFD: high-fat diet; iWAT: inguinal white adipose tissues; MAP1LC3A/LC3A: microtubule-associated protein 1 light chain 3 alpha; MBKO; muscle-specific bdnf knockout; IL6/IL-6: interleukin 6; MCEE: methylmalonyl CoA epimerase; MFF: mitochondrial fission factor; NTRK2/TRKB: neurotrophic tyrosine kinase, receptor, type 2; OPTN: optineurin; PA: palmitic acid; PARL: presenilin associated, rhomboid-like; PDH: pyruvate dehydrogenase; PINK1: PTEN induced putative kinase 1; PPARGC1A/PGC-1α: peroxisome proliferative activated receptor, gamma, coactivator 1 alpha; PRKAA/AMPK: protein kinase, AMP-activated, alpha 2 catalytic subunit; ROS: reactive oxygen species; TBK1: TANK-binding kinase 1; TG: triacylglycerides; TNF/TNFα: tumor necrosis factor; TOMM20: translocase of outer mitochondrial membrane 20; ULK1: unc-51 like kinase 1.
Collapse
Affiliation(s)
- Palak Ahuja
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong
| | - Chun Fai Ng
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong
| | - Brian Pak Shing Pang
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong
| | - Wing Suen Chan
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong
| | - Margaret Chui Ling Tse
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China, Hong Kong
| | - Xinyi Bi
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong
| | - Hiu-Lam Rachel Kwan
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China, Hong Kong
| | - Daniel Brobst
- Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Oana Herlea-Pana
- Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
| | - Xiuying Yang
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Drug Target and Screening Research, Institute of Materia Medica of Peking Union Medical College, Beijing, China
| | - Guanhua Du
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines and Beijing Key Laboratory of Drug Target and Screening Research, Institute of Materia Medica of Peking Union Medical College, Beijing, China
| | - Suchaorn Saengnipanthkul
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Hye Lim Noh
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Baowei Jiao
- State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
| | - Jason K Kim
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.,Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Chi Wai Lee
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China, Hong Kong
| | - Keqiang Ye
- Department of Pathology, Emory University School of Medicine, Atlanta, USA
| | - Chi Bun Chan
- School of Biological Sciences, The University of Hong Kong, Hong Kong, China, Hong Kong.,State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong
| |
Collapse
|